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Cognitive impairments associated with schizophrenia are very frequent. They concern 
both neurocognition and social cognition, including facial emotion recognition. These 
impairments have a negative impact on the daily functioning, in particular the social and 
vocational rehabilitation of people with schizophrenia. Previous studies in this area clearly 
demonstrated the interest of cognitive remediation to improve neurocognitive and social 
cognitive functioning in schizophrenia. They also established clear links between facial 
emotion recognition skills and attentional processes. The present study compares the 
GAÏA s-face program (GAÏA arm), which focuses on facial emotion recognition processes, 
with the RECOS program (RECOS arm), a neurocognitive remediation therapy focus-
ing on selective attention. Forty people with schizophrenia were randomly distributed 
between each study arm and assessed pre- (T1) and post- (T2) therapy. The single-blind 
assessment focused on facial emotion recognition (the main criteria), symptoms, social 
and subjective functioning, and neurocognitive and social cognitive performance. Both 
programs were conducted by nurses after a 3-day training session. The study showed 
a significant improvement in facial emotion recognition performance in both groups, 
with a significantly larger effect in the GAÏA arm. Symptoms and social functioning also 
improved in the GAÏA arm, and certain neurocognitive and social cognitive processes 
improved in both study arms. Further studies are recommended, with larger population 
samples and a follow-up assessing the long-term preservation of these improvements.
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inTrODUCTiOn
Cognitive impairments associated with schizophrenia affect 
about four out of five patients. They significantly impact func-
tional recovery, and the social and vocational rehabilitation of 
people with schizophrenia (1–3). They may also impact all cogni-
tive processes, i.e., neurocognition (memory, attention, executive 
functions, and processing speed) and social cognition (4–6).
Social cognition can be defined as the ability to construct men-
tal representations about others, oneself and one’s relationships to 
others (5), and covers several processes. Five components of social 
cognition are mainly impaired in schizophrenia (6–9): theory of 
mind, attributional style, social perception, social knowledge, 
and the perception of emotions on faces and in prosody (i.e., the 
emotional information provided by variations in pitch, loudness, 
and speech flow).
The ability to understand the emotional state of others is, 
therefore, a key aspect of social cognition. Its function is to help 
adapt one’s behavior according to the “signs” other people give 
off. The misinterpretation of other people’s emotions or poor 
communication with one’s own emotions negatively impacts 
relationships, and leads to difficulty in joining social groups. 
Impaired emotion perception and expression in schizophrenia 
have been described since Bleuler (1911) (10), and facial emo-
tion recognition deficit is now clearly identified (11). Various 
studies showed that this deficit was a trait factor (12) and was 
observed with less intensity in family members not affected by 
the disease (13). Although facial affect recognition deficit is not 
specific to schizophrenia, its frequency and intensity are higher in 
schizophrenia than in other psychiatric disorders. Some authors 
suggested that facial affect recognition deficits might be a marker 
of vulnerability to the disease (14).
The origin of facial emotion processing deficits associated with 
schizophrenia is still not completely understood but is thought to 
result from the alteration of various processes.
Several authors (15–17) reported correlations between 
attention deficit and facial emotion recognition deficit. These 
correlations are supported by many neuroimaging studies that 
showing hypoactivity in the frontal cortex in patients with 
schizophrenia (18); the frontal cortex controls both executive 
and attentional skills, and is also involved in facial emotion 
recognition (19).
Other studies focused on patterns of visual attention to faces 
(20, 21): compared to healthy controls, people with schizophrenia 
showed reduced number and range of visual saccades, increased 
duration of fixation, and reduced attention to relevant features 
during emotion recognition tests.
Facial emotion recognition deficit is also frequently correlated 
with other difficulties in emotional information processing, 
especially the production of facial emotions (22, 23), and the 
processing of affective prosody (24). This may be caused by a 
deficit in a specific cognitive emotional processing module. This 
hypothesis is also supported by neuroimaging studies showing 
that the same brain regions are partly involved in the processing 
of facial and prosodic emotional information, most notably the 
upper right temporal cortex, the limbic system, and the prefrontal 
cortex (25, 26).
Recent research has explored the hypothesis of a gap in the 
processing of all facial information, including non-emotional 
information. In people with schizophrenia, such deficit may 
impair the ability to process configural information (i.e., the physi-
cal characteristics making up a face and the relations between its 
components), which can be common to all faces (i.e., first-order 
configural information) or specific to one face (i.e., second-order 
configural information). Maurer et al. (27) proposed a distinction 
between two processing methods operating at the same time: the 
holistic processing, in which facial information is processed as a 
whole, and the componential processing that involves a feature-
based analysis relying on second-order configural information 
processing (28). The impact of impaired configural information 
processing on facial emotion recognition deficit in people with 
schizophrenia is still poorly understood. However, the differences 
reported by various studies between patients with schizophrenia 
and healthy controls (14, 29) call for further investigation in this 
particular area.
Although the processes underlying social cognition disorders 
are not completely understood, cognitive remediation programs 
targeting social cognition or some of its components (especially 
theory of mind and the perception of facial emotions) have been 
recently developed (30–32). Cognitive remediation seems to be 
the most promising intervention to improve social cognition 
abilities and especially facial emotion recognition (32), whereas 
antipsychotic treatments have little effect on such processes 
(33). Most social cognitive remediation programs are group 
oriented and based on “standardized” exercises, which may be 
detrimental to patients. It also makes it more difficult to adapt 
strategies to each participant’s cognitive and clinical profile. 
Furthermore, groups do not facilitate individualized homework 
tasks, which are designed to help transfer therapeutic strategies 
into daily life.
In the field of neurocognition, recently, several computer-
assisted cognitive remediation programs have been developed 
(34–37). Computer-assisted programs give immediate feedback 
on the participant’s performance and adjust both the difficulty 
of the exercises and reinforcement methods (38). Furthermore, 
it seems that prolonged computer stimulation encourages neural 
plasticity and the learning of new coping strategies, which are 
central to cognitive remediation therapy (39). Finally, individual 
cognitive remediation provides exercises adapted to the partici-
pant’s cognitive profile and functional goals (40), and takes into 
account the metacognitive difficulties associated with schizo-
phrenia (41–43).
In the field of social cognition, the use of computer-assisted 
methods seems just as relevant, especially to improve emotion 
recognition. The advantage of this technology lies in the control 
of all the processes at play in social interactions, and the develop-
ment of progressive training. Furthermore, it provides a secure 
environment where the person can practice without risking nega-
tive repercussions in real life or generating much anxiety. Using 
a virtual environment also limits the bias of attributing emotions 
to others according to the participant’s own emotions. However, 
the presence of a collaborative therapist remains essential, espe-
cially to encourage the transfer and adaptation of strategies into 
real-life situations (40). Furthermore, the role of the therapist 
FiGUrE 1 | Group allocation.
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also includes encouraging the participant formulate concrete 
objectives (increasing, therefore, motivation), and developing 
individualized exercises to achieve these goals throughout 
therapy; these exercises will then be put into practice during and 
outside the sessions.
According to these data, both neurocognitive remediation, 
focusing on attentional processes, and social cognition reme-
diation, focusing on emotional perception, should increase facial 
affect recognition in people with schizophrenia. From a clinical 
perspective, it would be interesting to compare the effects of these 
strategies on symptoms, and cognitive and social functioning.
The GAÏA s-face (Schizophrenia- Facial Affects recognition 
Cognitive Enhancement) program (44, 45) is an individual, 
computer-assisted cognitive remediation therapy focusing on 
facial emotion recognition. The present controlled efficacy study 
compares the GAÏA s-face program with the RECOS program, 
an individual, computer-assisted neurocognitive remediation 
therapy focusing on attentional processes (46, 47).
METHODS
Study Design
Clinically stable people with schizophrenia, according to the 
DSM-IV-TR criteria (48), were recruited in four psychiatric 
centers in France. They were randomly distributed between two 
active treatment arms, namely GAÏA and RECOS. The assess-
ments were blind to group allocation and carried out at baseline 
(T1 = week 0) and post-treatment (T2 = week 11).
The main treatment outcome measure was the TREF (facial 
emotion recognition test) total score (49).
Secondary measures included clinical ratings, neurocognitive 
and social cognitive measures, and psychosocial evaluation.
The study was approved by local ethics authority (CPP Lyon 
Sud–Est VI, project no. AU  940), and declared to the national 
authority (ANSM: project no. 2011-A00793-38) and on clinical-
trials.gov (project ID: NCT01607424).
After a complete description of the study objectives and 
procedures, each participant signed a written informed consent.
The two arms of this parallel-group randomized clinical trial 
consisted of active and comparable interventions in terms of 
number of sessions, but also in terms of therapist roles and mate-
rial used. This constitutes an ethical choice, since each participant 
was provided with an intervention designed to improve his/her 
cognitive performance and social and professional integration 
(3, 7, 50). The study design also makes it possible to observe 
and compare the specific effects of each program on the various 
cognitive and functional outcomes.
Both interventions were carried out by nurses (except one 
occupational therapist in the RECOS arm) who all attended 
a specific 3-day training session. Each nurse was involved in a 
single arm of the study to ensure equal motivation and invest-
ment among therapists for both programs. The possibility to 
assess the nurses’ skills in providing effective individual cognitive 
remediation interventions might represent a cost-efficient solu-
tion to implement cognitive remediation in the routine care of 
schizophrenia, for the benefit of a larger number of people.
Participants
Forty in- and out-patients with stable schizophrenia were included 
in the trial (see Figure  1). Inclusion criteria were as follows: 
DSM-IV-TR criteria for schizophrenia (48), with clinical stabil-
ity confirmed after examination by the psychiatrist-investigator 
from the recruiting department; age 18–45; impairment of facial 
affect recognition confirmed by a TREF test score below 69% 
(SD = −1) (49); native French speakers.
Exclusion criteria included history of neurological illness or 
trauma; use of somatic medication with cerebral or psychological 
impact; alcohol or drug addiction (except tobacco); and other 
TaBlE 1 | Group comparison after randomization.
Test/measure GaÏa arm rECOS arm p-value
n allocation 21 19
Gender ratio (w/m) 0.19 0.21 0.89 (ns)
Age 31.71 33.74 0.37 (ns)
TREF total score 55.67% 54.17% 0.63 (ns)
PANSS total score 76.62 81 0.45 (ns)
Positive subscale 16.52 15.26 0.31 (ns)
Negative subscale 20.61 23.37 0.19 (ns)
Medication (chlorpromazine  
equivalent)
377.83 mg 335.52 mg 0.56 (ns)
AA
RECOS ARM AA
T1
Comprehensive 
Assessment 
Symptoms
Neurocognion
Social cognion
Funconal assessment / 
Definion of goals
- neurocognive impairments 
outcomes in daily life
- Personalized goals for the 
therapy
- Selecon of cognive funcons 
trained during the therapy
Only selecve aenon was 
trained in this study
AA Therapy
3 sessions per week
2 therapist-parcipant 
sessions
- 1 session of paper and pencil 
exercises
- 1 session of computerized 
exercises
1 home exercises
(without therapist)
T2
Comprehensive 
Assessment 
Symptoms
Neurocognion
Social cognion
AA
6 months 
follow-up
30 SESSIONS IN 10 WEEKS
Funconal assessment / 
Definion of goals
- Social cognive impairments 
outcomes in daily life
- Personalized goals for the 
therapy
Therapy
3 sessions per week
2 therapist-parcipant 
sessions
1 home exercises (without 
therapist)
3 successive phases: 
- photographs exercises 
- computerized exercises
- generalizaon
GAÏA ARM
FiGUrE 2 | Steps of GaÏa and rECOS interventions.
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cognitive remediation therapy during the period of inclusion in 
the study.
At T1, there was no significant difference between the GAÏA 
and RECOS groups in age, gender, symptom intensity measured 
with the Positive And Negative Symptoms Scale [PANSS (51)], 
medication doses converted into chlorpromazine equivalent (52), 
or facial emotion recognition skills measured with the TREF 
(see Table 1).
interventions
The participants were assessed before (T1) and after (T2) 
intervention. However, both RECOS and GAÏA s-face programs 
recommend a 6-month follow-up phase, with a 30-min meeting 
every 2  weeks between the participant and the therapist (see 
Figure 2). This meeting, during which no cognitive remediation 
exercises are performed, is aimed at reinforcing the functional 
outcomes of cognitive remediation (45, 53).
RECOS (Control Arm)
RECOS is an individual neurocognitive remediation therapy with 
proven effectiveness (35). In its usual form (53), it targets one to 
three out of six neurocognitive functions (verbal memory, work-
ing memory, executive functions, memory and visuo–spatial 
attention, selective attention, and processing speed), according to 
the functional implications of their impairments and the partici-
pant’s cognitive and clinical profile. The RECOS program comes 
after a comprehensive assessment of cognitive functions, clinical 
symptoms, and social functioning. The therapy consists of three 
1-h sessions per week, always alternating paper-and-pencil ses-
sions, computer sessions, and home (without therapist) exercises 
designed to encourage functional benefits.
In the present study, all the patients working with RECOS 
were trained on selective attention, since it was demonstrated 
that attentional deficits were linked to facial emotion process-
ing deficits (15–17). All the participants randomly assigned to 
the RECOS group attended 30  sessions during a 10-week-long 
treatment.
GAÏA s–Face (Experimental Arm)
GAÏA s-face (44, 45) is an individual, social cognitive remediation 
program focusing on facial emotion processing. The GAÏA pro-
gram comes after a comprehensive assessment of neurocognition, 
TaBlE 2 | Comprehensive cognitive assessment.
neurocognition assessment Social cognition assessment
Visuospatial memory: brief visual 
memory test – revised (59)/
scores: total recall; delayed recall; 
recognition
Attributional style: Ambiguous Intentions 
Hostility Questionnaire (60)/scores: 
ambiguous situations HB; AB; total 
score
Working Memory: 
 – Digital span (61)/Raw score 
 – TAP (62) – Working 
memory – level 3/scores: TR; 
errors; omissions
 – Corsi blocks (63)/Raw score
Emotion perception: 
 – TREF (49)-main criteria
 – Levels of Emotional Awareness 
Scale (64)/total score
Selective Attention: 
 – D2 (65)/scores: GZ; F%; KL
 – TAP (62) – divided attention- 
visual modality; auditory 
modality; combined modality/
scores: TR; errors; omissions
Empathy: Questionnaire of Cognitive 
and Affective Empathy (66)/cognitive 
and affective scores
Executive functions: 
 – Trail Making Test (67)/B-A score
 – Key search from BADS (68)/Raw 
score
 – Verbal fluency (69)/Raw score
Theory of Mind: 
 – Reading the mind in the eyes test 
(70)/total score
 – Versailles-Situational Intention 
Reading (71)/total score
 – Hinting task (72)/total score
Processing speed: Code (61)/Raw 
score
TAP: Test of Attentional Performance; BADS: Behavioral Assessment of the 
Disexecutive syndrome.
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social cognition, clinical symptoms, and social functioning. The 
therapy is spread over 30 sessions: three 1-h sessions per week 
for 10 weeks. One of these sessions (called the transfer session) 
is performed without the therapist in the participant’s everyday 
environment. The GAÏA program is divided into three phases: 
(1) an exercise phase with photographs, aiming to develop strate-
gies to recognize and discriminate joy, anger, and sadness. (2) A 
computerized exercise phase using videos, to adapt the strategies 
developed on photographs to dynamic situations with five levels 
of increasing difficulty. (3) A generalization phase, consisting of 
at least five therapist–participant sessions and further computer-
ized exercises determined according to the participant’s profile 
and requests, to recognize and discriminate other basic emotions 
(fear, disgust, and contempt) and to work on complex emotions.
assessment
Main Outcome Measure
The main outcome was measured with the TREF (Facial Emotions 
Recognition Task) total score (49).
The TREF consists of 54 photographs of six male and female 
faces expressing disgust, contempt, fear, anger, sadness, and joy. 
Each emotion is represented with color photos of four different 
models with nine intensity levels from 20 to 100%. The different 
emotional expression intensities were obtained using a mor-
phing technique blending the neutral and maximal expression 
photographs for each emotion and model. The 54 photographs 
are organized in six lists. The lists are presented in a randomized 
order.
For each photograph, the task is to select the right emotion 
from a six-label list: fear, sadness, contempt, anger, joy, and 
disgust. Each photograph is presented for 10 s; there is no time 
limit to answer.
The total score is the percentage of correctly labeled emotions. 
In a previous study (49), we demonstrated that the average score 
of correct answers in a first population of control subjects was 
76.45% (SD = 7.44).
Participants enrolled in this study all presented facial 
emotion recognition impairment, confirmed by a TREF score 
below or equal to 69% (SD = 1 below the mean of the reference 
population).
Secondary Outcome Measures
Clinical Assessment
Symptoms were assessed with the PANSS (51). Total, positive 
subscale, and negative subscale scores were used.
Delusional beliefs were assessed with the 21-item Peters et al.’s 
Delusions Inventory (PDI21) (54). Total scores were used.
Functional and Subjective Assessment
Insight was assessed with the Insight Scale (IS) (55). Total scores 
were used.
Self-esteem was assessed with the Self-Esteem Rating Scale 
(SERS) (56, 57). Total scores were used.
Social functioning was assessed with the social autonomy scale 
(“Echelle d’Autonomie Sociale”-EAS) (58). Total score, “social 
relatedness (SR),” and “relationship with the environment” (RE) 
sub-scores were used.
Cognitive Assessment
A comprehensive neuropsychological assessment of neurocogni-
tion and social cognition (see Table 2) was performed.
Statistical analysis
Analyses of variance and t-tests were used to investigate group 
differences. When results were significant (p-value inferior to 
5%), Fisher’s least significant difference (LSD) was used. Data 
were analyzed using statistica (v.10). If significant differences 
existed between the groups at T1, t-tests were used on the change 
between T1 and T2, in order to compare evolution of measures.
To assess evolution on neuropsychological tests, statistical 
analyzes were performed for each cognitive process (visuospatial 
attention and memory, working memory, executive functions, 
selective attention, and processing speed). The scores were con-
verted into standard notation in order to obtain an overall score 
per process.
The treatment effect magnitude was calculated with Cohen’s d 
effect size between T2 and T1 in each group.
Hypothesis
A significant improvement in TREF scores was expected for 
GAÏA participants compared to the RECOS arm at T2. However, 
an improvement in facial emotion recognition performance was 
expected in both study arms at T2 compared to T1, since GAIA 
specifically targets emotion recognition and RECOS focuses on 
the role of attentional processes in facial emotion recognition 
(15, 17).
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Various studies have shown the role of social cognition deficits 
in the generation and maintenance of the positive and negative 
symptoms of schizophrenia (15, 33, 73). Thus, decreased PANSS 
scores were expected in the GAIA arm at T2 compared to T1. 
According to the literature (34), this effect was not expected for 
RECOS participants.
No special assumption was made on the effects of each inter-
vention on delusional beliefs measured with the PDI21.
Social cognition has been described as a mediator between 
neurocognition and social functioning (33). According to this 
model, an improving effect of the GAIA s-face intervention 
was expected at T2 on social autonomy in comparison with the 
RECOS program.
In a previous study (34), the RECOS program showed a posi-
tive effect on self-esteem. This effect may be due to metacogni-
tive skills and verbalization techniques raising the participants’ 
awareness of their own resources, and to the problem-solving 
strategies they implement to manage their daily life. A large 
part of this methodology has been implemented in the GAÏA 
s-face program. Thus, an improvement of the participants’ 
self-esteem was expected at T2 in comparison with T1 in both 
study arms.
The literature describes neurocognition and social cognition as 
separate processes (74, 75). No effect was, therefore, expected on 
neurocognitive assessment in the GAÏA arm. By contrast, RECOS 
participants receiving cognitive remediation targeting selective 
attention were expected to show improved performances at T2 
in tasks targeting this process compared to GAÏA participants.
Social cognition is defined as a set of separate processes (5). 
A specific effect of the GAÏA s-face intervention on every test 
measuring emotional processing was expected at T2 vs. T1. No 
effect of the RECOS program was expected on social cognition 
tests, apart from facial emotion recognition, as described above.
rESUlTS
Results are presented in Tables 3–5.
Main Outcome
GAÏA participants showed an average increase of 16.21% on the 
TREF total score at T2 compared to T1 (p < 0.0001), whereas 
RECOS participants showed an average increase of 8.43% 
(p <  0.009) for the same period. Both groups showed signifi-
cantly improved T2–T1 TREF means total score (see Figure 3; 
Table 3).
Although there was no difference between the two groups 
at T1 (p =  0.71), a significant difference in favor of the GAÏA 
arm was found when comparing the results at T2 (p =  0.005). 
GAÏA participants showed significantly improved TREF scores 
in comparison with RECOS participants.
Each group showed a strong effect size, with a greater effect 
in the GAÏA arm (d = 2.41) than in the RECOS arm (d = 0.98).
Secondary Outcomes
Clinical Measures
No effect was found at T2 on PDI21 measures of delusional beliefs 
in either group.
The GAÏA group showed significantly decreased symptoms 
on the T2–T1 mean (p < 0.001), measured with the PANSS total 
score. This decrease was also significant on the positive subscale 
score (p < 0.01) and the negative subscale score (p < 0.001).
No significant effect was found on the T2–T1 mean PANSS 
total score (p  =  0.66), and positive (p  =  0.08) and negative 
(p = 0.63) subscale scores in the RECOS group (see Table 4).
While no significant difference was observed between the 
two groups in PANSS scores and sub-scores after randomiza-
tion (Table 1), a significant difference in the negative sub-score 
appeared at T1, when taking into account drop-out participants 
(see Table 4 and Figure 4). Nevertheless, a significant difference 
in favor of the GAÏA arm was found when comparing the results 
at T2 on the PANSS total score (p < 0.001). No significant effect 
was found on the positive subscale between the interventions. 
The difference in favor of the GAÏA arm on the negative subscale 
is even more significant at T2 (from p < 0.01 to p < 0.0001).
Psychosocial and Functional Outcomes
No effect was found at T2 on measures of insight with the IS, nor 
on self-esteem measured with the SERS, in either group.
Measures of social autonomy with the EAS significantly 
improved (i.e., decreased scores were observed) in the GAÏA arm 
on the T2–T1 mean (see Table 4; Figure 5). This improvement 
was found on the total score (p < 0.01), “SR” subscore (p < 0.04), 
and ‘‘RE’’ subscore (p < 0.01). No effect was found on pre–post 
measure in the RECOS arm.
A significant difference in favor of the GAÏA arm was found 
when comparing the results at T2 on the EAS total score and SR 
sub-score (respectively, p < 0.0001 and p < 0.02 – see Table 4). 
A significant difference in favor of the GAÏA arm was observed 
on “RE” score at T1 (p < 0.003); however, the difference was even 
more significant at T2 (p < 0.0001).
Cognitive Functioning Measures
Neurocognitive Assessment
Social cognitive outcomes are reported in Table 5.
A group effect was found in selective attention on the T2–T1 
mean. The participants of the RECOS arm showed significantly 
improved performances at T2 (p < 0.0001). No effect was found 
in the GAÏA arm (p = 0.4).
Despite a difference in favor of the GAÏA arm at T1 (Table 5), the 
significant difference found at T2 was in favor of the RECOS arm.
Both groups significantly improved in processing speed, with 
a larger effect in the RECOS group in comparison with the GAÏA 
group (respectively, p < 0.0001 and p < 0.03). No effect was found 
in group comparison.
Participants in both groups showed significantly improved 
performance in visuospatial attention and memory at T2 in 
comparison with T1 (see Table  5), but no effect was found in 
group comparison.
A group effect was found in working memory at T2. GAÏA 
participants showed significantly improved performance at T2 
in comparison with T1 (p <  0.01) and with the RECOS arm 
(p < 0.005).
No effect was observed in either group during executive func-
tion assessment on T2 vs. T1 (GAÏA p < 0.08; RECOS p < 0.75). 
TaBlE 5 | Evolution in neurocognitive assessment.
neurocognition domain GaÏa (n = 18) rECOS (n = 15) GaÏa vs. rECOS
T2–T1 mean (p-value) T2–T1 mean (p-value) T1 (p-value) T2 (p-value) T2–T1 (p-value)
Processing speed 0.03* 0.0001*** 0.0001*** 0.0001*** 0.23
Selective attention 0.40 0.0001*** 0.01** 0.05* 0.00018***
Visuospatial processes 0.001*** 0.02* 0.34 0.13
Working memory 0.01** 0.25 0.27 0.005** –
Executive functions 0.08 0.75 0.40 0.02* –
Bold values indicate the significant result; *p < 0.05; **p < 0.01; ***p < 0.001.
TaBlE 4 | Evolution in clinical, psychosocial, and functional assessment.
GaÏa (n = 18) rECOS (n = 15) GaÏa vs. rECOS
T2–T1 mean (p-value) T2–T1 mean (p-value) T1 (p-value) T2 (p-value) T2–T1 (p-value)
Symptoms
PANSS TOT 0.001*** 0.66 0.33 0.001*** –
PANSS POS 0.01** 0.08 0.42 0.08 –
PANSS NEG 0.001*** 0.63 0.01** 0.0001*** 0.066
PDI21 0.34 0.26 0.24 0.36 –
insight (Birchwood) 0.09 0.95 0.01** 0.1 0.26
Self-Estime (SERS) 0.27 0.19 0.25 0.42 –
Social autonomy
EAS TOT 0.01** 0.47 0.08 0.0001*** –
RE score (EAS) 0.01** 1 0.003** 0.0001*** 0.086
SR score (EAS) 0.04* 0.41 0.59 0.02* –
RE, relationship with the environment; SR, social relatedness.
Bold values indicate the significant result; *p < 0.05; **p < 0.01; ***p < 0.001.
TaBlE 3 | Evolution in social cognition assessment.
Social cognitive tasks GaÏa (n = 18) rECOS (n = 15) GaÏa vs. rECOS
T2–T1 mean (p-value) T2–T1 mean (p-value) T1 (p-value) T2 (p-value) T2–T1 (p-value)
Emotional processing
TREF (main criteria) 0.0001*** 0.01** 0.71 0.005** –
LEAS 0.03* 0.09 0.03* 0.14 0.007**
attributional style
AIHQ global 0.98 0.12 0.81 0.31 –
HB 0.08 0.53 0.63 0.36 –
AB 0.96 0.58 0.02* 0.07 0.69
Theory of mind
Hinting task 0.42 0.01** 0.17 0.05* –
V-SIR 0.61 0.29 0.77 0.21 –
RMET 0.26 0.95 0.28 0.84 –
Empathy
QCAE cognitive score 0.79 0.02* 0.45 0.33 –
QCAE affective score 0.63 0.45 0.52 0.07 –
V-SIR, Versailles-Situational Intention Reading test; RMET, Reading the Mind in the Eyes Test; LEAS, Levels of Emotional Awareness Scale; AIHQ, Ambiguous Intentions Hostility 
Questionnaire; QCAE, Questionnaire of Cognitive and Affective Empathy; (ns), no significant.
Bold values indicate the significant result; *p < 0.05; **p < 0.01; ***p < 0.001.
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Nevertheless, a significant difference in favor of the GAÏA arm 
was found at T2 in group comparison (p < 0.02).
Social Cognition Assessment
Social cognitive outcomes are reported in Table 3.
Emotion perception was measured with the TREF (main 
criteria) and the Levels of Emotional Awareness Scale (LEAS).
A group effect measured with the LEAS was found on T2 vs. 
T1 for GAÏA participants, whereas no difference was found in 
the RECOS arm. No significant difference was found in group 
comparison at T2, though a difference in favor of the RECOS 
arm existed at T1.
No significant difference was observed in either group 
on the T2–T1 mean in attributional style measured with the 
FiGUrE 4 | Evolution of PanSS scores, groups comparison.
FiGUrE 3 | Evolution of TrEF scores pre/post intervention.
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Ambiguous Intentions Hostility Questionnaire, nor in group 
comparison at T2.
The assessment of theory of mind included several tasks. The 
Hinting task scores of RECOS participants were significantly 
higher at T2 than T1, whereas no effect was found in the GAÏA 
group. A group effect was found at T2 in favor of the RECOS arm 
(p < 0.05).
No effect was found in either group on the Versailles-
Situational Intention Reading test, nor on the Reading the Mind 
in the Eyes test.
Empathy was measured with the Questionnaire of Cognitive 
and Affective Empathy. A significant increase was found between 
T2 and T1 in the cognitive empathy sub-score for the RECOS 
group (p < 0.02). No effect was observed in either group on the 
affective empathy sub-score nor in group comparison.
DiSCUSSiOn
The main results include improved facial emotion recognition 
performance in both groups, reduced symptoms and improved 
social functioning in the GAÏA group, and the improvement 
of some neurocognitive and social cognitive processes in both 
study arms.
The significant improvement in TREF results for the GAÏA 
arm compared to the RECOS arm is consistent with the data 
from the literature, since Kurtz and Richardson (32) already 
showed that facial emotion recognition could be improved using 
a specific remediation.
The improvement for RECOS participants was an expected 
effect, based on previously demonstrated links between selective 
attention and facial emotion recognition skills (15–17).
FiGUrE 5 | Evolution of social autonomy, EaS scores pre/post intervention.
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Various hypotheses may explain the significantly greater 
improvement of the GAÏA group in facial emotion recognition 
skills compared to the RECOS group.
The GAÏA program learns participants to focus on relevant 
facial features to recognize emotions; this specific training 
probably helped them directly reuse the strategies learned 
during cognitive remediation to perform the TREF test. As for 
the RECOS group, the ability to select and focus on relevant 
facial features may be considered as a transfer and generali-
zation effect of the strategies they practiced during cognitive 
remediation.
Previous research has shown that modifications in the pattern 
of visual attention to faces were associated with facial emotion 
recognition deficit (20, 21). The GAÏA program probably has a 
positive effect on the pattern of visual attention to faces, sup-
ported by an (unexpected) positive effect on visuospatial abilities 
on pre–post analysis. However, further studies should explore 
this hypothesis.
The significant improvement of schizophrenia symptoms 
measured with the PANSS at T2 in the GAÏA arm was expected. 
Various studies have shown correlations between social cogni-
tion, especially facial emotion recognition, and both positive 
(15, 73) and negative (33) symptoms.
However, links between symptoms and social cognition are 
not straightforward (33), since reduced symptoms after GAÏA 
s-face therapy may be a transfer and generalization effect of the 
benefits of cognitive remediation.
Symptoms did not improve at T2 in the RECOS arm, hypotheti-
cally because of a lack of connection between neurocognition and 
positive symptoms (76), unlike social cognition that may act as a 
mediator between neurocognition and negative symptoms (33). 
The improvement of negative symptoms after neurocognitive 
remediation, thus, constitutes a higher transfer level than facial 
emotion recognition.
Nevertheless, it will be important to observe whether these 
benefits are sustainable and whether a generalization effect occurs 
in the RECOS arm after follow-up, as it was shown in a previous 
study (34).
A significant improvement in social autonomy was meas-
ured with the social autonomy scale (EAS) (58) for GAÏA 
participants. Such improvement is consistent with the data 
from the literature, which describe social cognition as a 
mediator between neurocognitive and social functioning (77, 
78). Couture et al. specifically showed correlations between the 
perception of emotions and community functioning, “social 
behavior in the milieu” and “social skills,” which seems to match 
the improvement in the ‘‘relationship with the environment’’ 
(RE) and ‘‘social relatedness’’ (SR) subdivisions of the EAS. We 
suggest that this effect was encouraged by individual therapy, 
which helped introduce a metacognitive dimension to the ses-
sions with the therapist, and adapt exercises to the motivations 
and clinical profile of participants during the transfer sessions. 
Furthermore, the structure of the GAÏA s-face program, offer-
ing computer exercises adjusted to the participant’s everyday 
environment, may have facilitated the transfer and generaliza-
tion of benefits to everyday life.
This study did not show any improvement in social function-
ing for RECOS participants, probably because transfer between 
neurocognition and social functioning is less straightforward 
than between social cognition and social functioning. However, 
the program is open to incorporate a metacognitive dimension 
and individualization, to facilitate the transfer of strategies to 
daily tasks.
It will be important for future studies to observe how social 
functioning evolves in the long term for both programs, whether 
the encouraging results of the GAÏA arm are long-lasting, and 
whether functional benefits appear later for the RECOS arm, 
since the generalization of cognitive benefits requires a certain 
amount of time.
An improvement in self-esteem was expected in both arms, 
but this study did not evidence this improvement. RECOS 
had been proven effective in this area in a previous study (35) 
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related to therapeutic strategies, particularly the research and 
generation of the participant’s own strategies and the positive 
reinforcement provided by the therapist. These strategies were 
introduced into the GAÏA s-face program. It will be important 
for future studies to perform the same measures with more 
experienced therapists and assess subjective benefits for the 
participants as well.
This study also highlighted the benefits of cognitive remedia-
tion with the RECOS program. The RECOS group underwent a 
training program focusing on selective attention (in its usual 
version, the program provides targeted cognitive remediation, 
adapted to the participant’s cognitive profile) and results at T2 
showed a significant improvement in selective attention, process-
ing speed, and visuospatial attention tasks.
The GAÏA group also showed positive effects on neuropsycho-
logical assessment at T2. Besides visuospatial functions, improved 
working memory was observed after the therapy. Several hypoth-
eses may explain this unexpected effect. Some neuropsychological 
tests measuring working memory skills used visual modality and, 
therefore, also required visuospatial memory skills. Improvement 
in memory and visuospatial attention for GAÏA participants may 
underlie improvement in working memory.
Furthermore, the GAÏA s-face therapy requires that par-
ticipants undertake verbal and visual learning, especially during 
photograph exercises and generalization phases, where they have 
to assimilate cues to recognize facial expressions of basic emo-
tions. Therapists probably developed strategies with participants 
to facilitate these acquisitions and participants may have reused 
such strategies during T2 working memory tests. However, it will 
be necessary to repeat these results in future studies designed to 
test these hypotheses.
The assessment of social cognition evolution at T2 in the 
GAÏA arm showed a significant improvement in the partici-
pants’ performance in tests measuring emotional perception. 
Because of the specific nature of the LEAS (66), the signifi-
cantly increased scores in this test could be a first step toward 
improved empathy skills; however, no improvement was found 
in this area.
Nonetheless, this targeted increase seems in accordance with 
the literature, which defines social cognition as a complex process 
with partially independent components (6, 79).
A significant improvement was observed in one of the 
theory of mind tests [the Hinting task (72)] and in cognitive 
empathy measured with the QCAE for RECOS participants. 
The Hinting task assesses the ability to understand implicit 
components within sentences from daily life situations; the 
QCAE (cognitive subscore) measures a person’s ability to 
consider a situation from someone else’s perspective. Such 
improvement may be partly explained by improved attention 
skills, enabling participants to better focus on situations rather 
than on their own thoughts or feelings, and better detect inten-
tions in verbal messages.
Limitations of the present study mainly include small sample 
size and lack of evaluation of the long-term preservation of the 
benefits.
Further studies are needed to confirm the positive outcomes 
of the present study and verify their sustainability.
The potential impact on the subjective quality of life of the 
participants should be assessed in future studies, using standard-
ized assessment and real-life social functioning criteria.
Finally, further studies will have to explore the effects of the 
GAÏA s-face program on every social cognitive process (social 
perception and social knowledge were not assessed in this study). 
Comprehensive social cognition test batteries are currently under 
development (80); they should help better understand the inter-
actions between each process.
COnClUSiOn
Although the understanding of the cognitive mechanisms 
improved by the GAÏA program is still incomplete, the results of 
this study show the applicability and effectiveness of the program 
to improve facial emotion recognition skills, reduce positive 
and negative symptoms in schizophrenia, and improve social 
functioning.
Positive results were obtained for both programs in the main 
criteria. Facial emotion recognition skills improved in both arms, 
selective attention was significantly improved in the RECOS 
group, which received specific training targeting these processes, 
and the GAÏA program showed positive effects on symptoms and 
social functioning. These results were obtained with cognitive 
remediation provided by nurses after a 3-day training session. This 
is an interesting prospect for the spread of cognitive remediation 
and its potential inclusion into the routine care of schizophrenia 
alongside drug treatment, psychoeducation, social skills training, 
and psychotherapy.
Facial emotion processing is also impaired in other disorders, 
so it would be interesting for future studies to explore whether the 
GAÏA s-face program is effective in people with diseases, such as 
autism spectrum disorders or 22q11.2 deletion syndrome.
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